Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
4d
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
From new VPs to fresh project managers, see who’s been hired, promoted and honored: It’s our weekly Personnel File roundup.
BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the ...
Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...
Frontline Road Safety today announced that Bain Capital has agreed to acquire the Company from The Sterling Group.
BAIN Capital is nearing a deal to buy Mitsubishi Chemical Group’s pharmaceutical unit, sources familiar with the matter said, ...
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
Wells Fargo analyst Finian O’Shea maintained a Buy rating on Bain Capital Specialty Finance (BCSF – Research Report) today and set a price ...
Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...
Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results